Implementation of an adapted family-based eating disorder protocol enhanced with dietician support in a community private practice: evidence of full remission
Abstract
Treatment of adolescent eating disorders (EDs) has been hampered by the challenge of transporting Family-Based Treatment (FBT) to community clinicians. This case series study examined the effectiveness of an enhanced FBT protocol implemented by a private practitioner. Twenty-five patients with a DSM-5 ED diagnosis received a week of intensive, FBT-derived treatment followed by an outpatient protocol that enhanced traditional FBT by including consultation with a dietician and planned feared food exposures (M = 19.70 sessions). Percent expected body weight (%EBW), depression, and ED questionnaires (e.g. EDI-3) were obtained at the beginning of treatment and at 6 months. All 20 treatment completers achieved weight restoration. Substantial improvements (ES 0.96-2.11) were seen in %EBW, ED scores, and depression. Seventy-nine percent attained physical and psychological remission, 10% were "partially recovered," and 10% continued clinically elevated ED symptoms. An empirically informed, enhanced FBT protocol implemented by a private clinician produced weight restoration and ED symptom improvement within 6 months.
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.